Immunological Effect of the drug “Immune”- an Ayurveda medication in COVID-19 patients- A Randomized Control Trial

Abstract

Introduction: The Pandemic of SARS COV-2 continues to be a global health threat which has affected 140 million cases all over the world with 3.01million deaths with the main underlying main cause of raised inflammatory markers. India is well known for the birth of Ayurveda – the potential therapeutic agents have been developed having combination of already proven drugs for research. Objectives: To measure the effect of drug- “Immune” on the neutralizing antibody levels along with inflammatory markers among mild to moderate symptomatic COVID-19 subjects. Material and methods: Triple blinded Randomized Controlled Trial was adopted in our study among mild and moderate cases of COVID-19. Two groups- each having 25 subjects were intervened along with standard care of treatment where one was getting the drug immune consisting of Withania somnifera , glycrrhizine gabra , Cederus Deodara and Leptadenia Reticulata in Arka preparation and other were getting placebo which was blinded by labelling as drug A and Drug B. These two groups were followed up for antibody testing and inflammatory markers such as interleukin-6,D-dimer,serum ferritin and lactate dehydrogenase were also assessed. Results: There was a statistical significant rise in antibody titres(P value<0.05) with drug A compared to drug B which was later revealed to be drug immune and we could also found reduction in inflammatory marker mainly lactate dehydrogenase. Conclusion: This drug “Immune” proved to be of clinical significance with raised antibody titre and reduction of some of the inflammatory markers. And this can play a pivotal therapeutic agent to reduce the morbidity and mortality associated with SARS COV-2